The findings from this systematic review have several important implications for clinical practice, CSF biomarkers, particularly those like α-synuclein, NfL, and DJ-1, can aid in the early detection of PD even before motor symptoms become prominent. This evidence concerns the gene SNCA and Parkinson disease.